Aytu BioPharma (STU:AY20) Days Payable : 241.35 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aytu BioPharma Days Payable?

Aytu BioPharma's average Accounts Payable for the three months ended in Sep. 2024 was €10.94 Mil. Aytu BioPharma's Cost of Goods Sold for the three months ended in Sep. 2024 was €4.14 Mil. Hence, Aytu BioPharma's Days Payable for the three months ended in Sep. 2024 was 241.35.

The historical rank and industry rank for Aytu BioPharma's Days Payable or its related term are showing as below:

STU:AY20' s Days Payable Range Over the Past 10 Years
Min: 109.52 Med: 328.07 Max: 3826.28
Current: 182.94

During the past 13 years, Aytu BioPharma's highest Days Payable was 3826.28. The lowest was 109.52. And the median was 328.07.

STU:AY20's Days Payable is ranked better than
81.83% of 952 companies
in the Drug Manufacturers industry
Industry Median: 85.205 vs STU:AY20: 182.94

Aytu BioPharma's Days Payable declined from Sep. 2023 (264.86) to Sep. 2024 (241.35). It may suggest that Aytu BioPharma accelerated paying its suppliers.

Aytu BioPharma Days Payable Historical Data

The historical data trend for Aytu BioPharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aytu BioPharma Days Payable Chart

Aytu BioPharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Days Payable

Get a 7-Day Free Trial

303.42

158.84

114.64

110.75

164.64

Aytu BioPharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															264.86	171.20	151.46	156.45	241.35

Competitive Comparison of Aytu BioPharma's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Aytu BioPharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aytu BioPharma's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aytu BioPharma's Days Payable distribution charts can be found below:

* The bar in red indicates where Aytu BioPharma's Days Payable falls into.

Aytu BioPharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Aytu BioPharma's Days Payable for the fiscal year that ended in Jun. 2024 is calculated as

	Days Payable (A: Jun. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2023 )	+	Accounts Payable (A: Jun. 2024 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2024 )	*	Days in Period
=	( (12.44	+	9.699)	/	2 )	/	24.541	*	365
=	11.0695					/	24.541	*	365
=	164.64

Aytu BioPharma's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (9.699	+	12.175)	/	2 )	/	4.135	*	365 / 4
=	10.937					/	4.135	*	365 / 4
=	241.35

Aytu BioPharma Days Payable Related Terms

Thank you for viewing the detailed overview of Aytu BioPharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Aytu BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aytu BioPharma Inc (STU:AY20) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AYTU:USA 0A8M:UK

Address

7900 East Union Avenue, Suite 920, Denver, CO, USA, 80237

Website

https://www.aytubio.com

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Aytu BioPharma Headlines

No Headlines